Aridis Pharmaceuticals Stock Annual Yield
Aridis Pharmaceuticals fundamentals help investors to digest information that contributes to Aridis Pharmaceuticals' financial success or failures. It also enables traders to predict the movement of Aridis Pink Sheet. The fundamental analysis module provides a way to measure Aridis Pharmaceuticals' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Aridis Pharmaceuticals pink sheet.
Aridis |
Aridis Pharmaceuticals Company Annual Yield Analysis
Aridis Pharmaceuticals' Yield generally refers to the amount of cash that is paid back to the owner of a security over a specific time (usually one year). It is expressed as a percentage of current market price, and usually amounts to all the interests and/or dividends paid over a given period. A higher yield allows the shareholders to generate returns on their investments sooner. However, investors should also be aware that a high yield may be a result of market turmoil or increased price volatility.
Small firms, start-ups, or companies with high growth potential typically do not pay out dividends or distribute a lot of their profits. These companies will have small yield. Alternatively, more established companies, ETFs, and funds that invest in bonds will have higher yields.
CompetitionIn accordance with the recently published financial statements, Aridis Pharmaceuticals has an Annual Yield of 0.0%. This indicator is about the same for the Biotechnology average (which is currently at 0.0) sector and about the same as Health Care (which currently averages 0.0) industry. This indicator is about the same for all United States stocks average (which is currently at 0.0).
Did you try this?
Run Options Analysis Now
Options AnalysisAnalyze and evaluate options and option chains as a potential hedge for your portfolios |
All Next | Launch Module |
Aridis Fundamentals
Return On Asset | -1.08 | ||||
Operating Margin | (9.58) % | ||||
Current Valuation | 12.11 M | ||||
Shares Outstanding | 36.21 M | ||||
Shares Owned By Insiders | 31.53 % | ||||
Shares Owned By Institutions | 11.60 % | ||||
Number Of Shares Shorted | 2 M | ||||
Price To Earning | (1.41) X | ||||
Price To Book | 5.40 X | ||||
Price To Sales | 7.33 X | ||||
Gross Profit | (22.61 M) | ||||
EBITDA | (29.51 M) | ||||
Net Income | (30.37 M) | ||||
Cash And Equivalents | 6.32 M | ||||
Cash Per Share | 0.36 X | ||||
Total Debt | 6.13 M | ||||
Debt To Equity | (0.18) % | ||||
Current Ratio | 0.41 X | ||||
Book Value Per Share | (0.77) X | ||||
Cash Flow From Operations | (29.13 M) | ||||
Short Ratio | 0.22 X | ||||
Earnings Per Share | (1.15) X | ||||
Price To Earnings To Growth | (0.02) X | ||||
Target Price | 10.0 | ||||
Number Of Employees | 37 | ||||
Beta | 0.78 | ||||
Market Capitalization | 13.24 M | ||||
Total Asset | 14.7 M | ||||
Retained Earnings | (195.67 M) | ||||
Working Capital | (25.27 M) | ||||
Current Asset | 27.39 M | ||||
Current Liabilities | 3.06 M | ||||
Z Score | -26.03 | ||||
Net Asset | 14.7 M |
Thematic Opportunities
Explore Investment Opportunities
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.
Other Consideration for investing in Aridis Pink Sheet
If you are still planning to invest in Aridis Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Aridis Pharmaceuticals' history and understand the potential risks before investing.
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Global Correlations Find global opportunities by holding instruments from different markets | |
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios |